For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. A new study finds that surgeons are a key influence.
Diagnostics allow for the identification of cancer types and other crucial biomarkers, and are used right through from discovery to market.
A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa’s poorest regions.
Tiny snippets of genetic material called microRNA may offer a way to detect conditions such as Alzheimer’s disease earlier, according to a new study.
Studies of breast cancer do not take sufficient account of patients’ race, ethnicity, economic status, education level, health insurance coverage, and other social factors, a group of scientists argue.
Cancer Research UK Cambridge Institute is pushing for the use of genetic testing to transform treatment of breast cancer with the Personalised Breast Cancer Programme.
Psychiatric disorders share many genetic variants, while neurological disorders appear more distinct, according to a new study from the Brainstorm Consortium.
Researchers from the Mayo Clinic recommends genetic testing for all pancreatic cancer patients as the new standard of care, after finding six genetic mutations in patients with no family history of the disease.
When it comes to understanding what makes people tick—and get sick—medical science has long assumed that the bigger the sample of human subjects, the better. New research suggests this big data approach may be wildly off the mark.
Researches have identified molecular features of testicular germ cell cancers that could inform future efforts to improve treatment decisions and help monitor patients to see if their cancer has come back.